Variability of peak expiratory flow rate as a prognostic index in asymptomatic asthma (Articolo in rivista)

Type

• Prodotto della ricerca (Classe)
• Articolo in rivista (Classe)

Label

• Variability of peak expiratory flow rate as a prognostic index in asymptomatic asthma (Articolo in rivista) (literal)

Anno

• 1984-01-01T00:00:00+01:00 (literal)

Alternative label

• Bellia V, Cibella F, Coppola P, Greco V, Insalaco G, Milone F, Oddo S, Peralta G (1984)
  Variability of peak expiratory flow rate as a prognostic index in asymptomatic asthma
  in Respiration (Basel, Print)
  (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori

• Bellia V, Cibella F, Coppola P, Greco V, Insalaco G, Milone F, Oddo S, Peralta G (literal)

Pagina inizio

• 328 (literal)

Pagina fine

• 333 (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume

• 46 (literal)

Rivista

• Respiration (Rivista)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#pagineTotali

• 6 (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo

• 3 (literal)

Note

• PubMe (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni

• Clinica Pneumologica dell'Università, Palermo Consiglio Nazionale delle Ricerche, Istituto di Fisiopatologia Respiratoria, Palermo (literal)

Titolo

• Variability of peak expiratory flow rate as a prognostic index in asymptomatic asthma (literal)

Abstract

• The prognostic relevance of an enhanced variability of peak expiratory flow rate (PEFR) throughout the day was evaluated in asthmatics in remission: it was expressed as the coefficient of variation (CV) of values recorded 4 times daily for 2 weeks. Outcome at 3, 6, and 12 months was assessed in 2 groups of 16 patients each, differing because of a CV respectively higher (group A) and lower (group B) than 8%. A significantly higher frequency of abnormal PEFR values during the subsequent 3 months was recorded in patients of group A, and found as correlated to the magnitude of CV; in the same group a significantly worse clinical status--scored on the basis of response to treatment--was pointed out. Therefore, a high CV of PEFR may be assumed as a reliable indicator of the risk of exacerbation--not otherwise predictable--both in a short and a longer term; on this basis home monitoring of PEFR may be recommended as a useful tool in the evaluation of all the cases of asthma in remission (literal)

Prodotto di

• Istituto di biomedicina e di immunologia molecolare \"Alberto Monroy\" (IBIM) (Istituto)
• Epidemiologia delle broncopneumopatie e di altre malattie croniche non comunicabili (ME.P01.014.001) (Modulo)
• Tecnologie Innovative per lo Studio dei Disturbi Respiratori nel Sonno (ME.P01.014.009) (Modulo)

Autore CNR

• FABIO CIBELLA (Persona)
• GIUSEPPE INSALACO (Unità di personale interno)

Incoming links:

Prodotto

• Istituto di biomedicina e di immunologia molecolare \"Alberto Monroy\" (IBIM) (Istituto)
• Tecnologie Innovative per lo Studio dei Disturbi Respiratori nel Sonno (ME.P01.014.009) (Modulo)
• Epidemiologia delle broncopneumopatie e di altre malattie croniche non comunicabili (ME.P01.014.001) (Modulo)

Autore CNR di

• GIUSEPPE INSALACO (Unità di personale interno)
• FABIO CIBELLA (Persona)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi

• Respiration (Rivista)